Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free CCCC Stock Alerts

C4 Therapeutics (CCCC) Institutional Ownership

C4 Therapeutics logo
$3.40 -0.25 (-6.85%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$3.43 +0.03 (+0.88%)
As of 07/24/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for C4 Therapeutics (NASDAQ:CCCC)

Current
Institutional Ownership
Percentage
78.81%
Number of
Institutional Buyers
(last 12 months)
58
Total
Institutional Inflows
(last 12 months)
$48.62M
Number of
Institutional Sellers
(last 12 months)
15
Total
Institutional Outflows
(last 12 months)
$28.17M
Get CCCC Insider Trade Alerts

Want to know when executives and insiders are buying or selling C4 Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CCCC Institutional Buying and Selling by Quarter

C4 Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/10/2026 Wasatch Advisors LP3,522,644$16.45M0.1%+18.9%3.186%
6/4/2026Seven Fleet Capital Management LP57,076$150K0.0%N/A0.052%
5/21/2026CTC Alternative Strategies Ltd.10,792$28K0.1%N/A0.010%
5/19/2026Bank of America Corp DE2,359,241$6.21M0.0%-1.2%2.134%
5/19/2026Stempoint Capital LP453,236$1.19M0.2%N/A0.410%
5/18/2026ADAR1 Capital Management LLC43,000$113K0.0%N/A0.039%
5/18/2026Readystate Asset Management LP49,586$130K0.0%N/A0.045%
5/16/2026SummitTX Capital L.P.10,466$28K0.0%N/A0.009%
5/16/2026Orbimed Advisors LLC856,353$2.25M0.0%-39.0%0.774%
5/15/2026OMERS ADMINISTRATION Corp59,700$157K0.0%-49.3%0.054%
5/14/2026Renaissance Technologies LLC2,461,815$6.48M0.0%+53.6%2.234%
5/14/2026Sei Investments Co.25,134$66K0.0%N/A0.023%
5/7/2026Dimensional Fund Advisors LP442,518$1.16M0.0%+49.3%0.402%
4/21/2026 Wasatch Advisors LP2,961,761$7.79M0.1%-31.8%3.035%
2/23/2026Virtu Financial LLC20,655$39K0.0%N/A0.021%
2/19/2026Invesco Ltd.268,350$513K0.0%+39.9%0.277%
2/18/2026XTX Topco Ltd104,458$200K0.0%-30.3%0.108%
2/18/2026Quadrature Capital Ltd133,112$254K0.0%N/A0.137%
2/18/2026Orbimed Advisors LLC1,404,902$2.68M0.1%-73.2%1.450%
2/18/2026Millennium Management LLC1,188,969$2.27M0.0%-41.3%1.227%
2/18/2026Man Group plc156,098$298K0.0%+72.9%0.161%
2/18/2026Intrepid Family Office LLC55,000$105K0.1%-21.4%0.057%
2/18/2026Engineers Gate Manager LP24,416$47K0.0%+49.9%0.025%
2/18/2026Bridgeway Capital Management LLC131,100$250K0.0%+64.1%0.135%
2/18/2026683 Capital Management LLC400,000$764K0.0%N/A0.413%
2/17/2026RA Capital Management L.P.8,000,000$15.28M0.2%N/A8.255%
2/17/2026Bain Capital Life Sciences Investors LLC7,171,910$13.70M1.0%+545.0%7.401%
2/17/2026Atom Investors LP104,964$200K0.0%N/A0.108%
2/17/2026ExodusPoint Capital Management LP62,165$119K0.0%N/A0.064%
2/17/2026Graham Capital Management L.P.102,198$195K0.0%+151.5%0.105%
2/16/2026Squarepoint Ops LLC136,054$260K0.0%+1,247.2%0.140%
2/16/2026OMERS ADMINISTRATION Corp117,700$225K0.0%N/A0.121%
2/16/2026Barclays PLC219,204$419K0.0%+409.0%0.226%
2/13/2026Marshall Wace LLP265,027$506K0.0%+149.4%0.273%
2/13/2026Hudson Bay Capital Management LP111,551$213K0.0%N/A0.115%
2/13/2026Charles Schwab Investment Management Inc.449,432$858K0.0%+28.2%0.464%
2/13/2026State Street Corp342,773$655K0.0%+19.3%0.354%
2/13/2026Wells Fargo & Company MN809,260$1.55M0.0%+4,236.9%0.835%
2/12/2026 Wasatch Advisors LP4,344,918$8.30M0.0%-10.5%4.483%
2/12/2026Jane Street Group LLC874,794$1.67M0.0%+329.7%0.903%
Iran War Shock: What I Was Told In That Private Meeting (Ad)

You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel

Because THIS is the real reason.
2/12/2026Renaissance Technologies LLC1,602,580$3.06M0.0%+71.0%1.654%
2/12/2026Dimensional Fund Advisors LP296,480$566K0.0%-15.1%0.306%
2/11/2026LPL Financial LLC243,305$465K0.0%+21.1%0.251%
2/10/2026Goldman Sachs Group Inc.1,089,020$2.08M0.0%+136.8%1.124%
2/9/2026Geode Capital Management LLC988,878$1.89M0.0%+36.3%1.020%
1/30/2026Delta Investment Management LLC20,000$38K0.0%N/A0.021%
1/14/2026 Hennion & Walsh Asset Management Inc.237,137$453K0.0%+15.7%0.245%
11/19/2025Caitong International Asset Management Co. Ltd19,146$43K0.0%N/A0.020%
11/17/2025Jacobs Levy Equity Management Inc.503,145$1.12M0.0%+13.9%0.519%
11/17/2025Voleon Capital Management LP28,420$63K0.0%N/A0.029%
11/17/2025 Wasatch Advisors LP4,852,741$10.77M0.1%-34.6%5.007%
11/17/2025Qube Research & Technologies Ltd115,973$257K0.0%N/A0.120%
11/17/2025Mariner LLC128,237$285K0.0%-3.4%0.132%
11/17/2025Bank of America Corp DE2,053,162$4.56M0.0%+2.2%2.119%
11/17/2025Algert Global LLC106,300$236K0.0%N/A0.110%
11/14/2025Zacks Investment Management13,043$29K0.0%N/A0.018%
11/14/2025Man Group plc90,278$200K0.0%+15.0%0.127%
11/14/2025Orbimed Advisors LLC5,235,146$11.62M0.3%-23.4%7.356%
11/14/2025Shay Capital LLC420,000$932K0.1%N/A0.590%
11/14/2025Two Sigma Investments LP834,726$1.85M0.0%+22.1%1.173%
11/14/2025Bridgeway Capital Management LLC79,900$177K0.0%-23.8%0.112%
11/13/2025BNP Paribas Financial Markets80,806$179K0.0%-60.8%0.114%
11/13/2025Jefferies Financial Group Inc.38,200$85K0.0%N/A0.054%
11/12/2025Dimensional Fund Advisors LP349,289$775K0.0%-19.1%0.491%
11/12/2025R Squared Ltd17,880$40K0.0%-41.5%0.025%
11/7/2025Crestwood Advisors Group LLC66,536$148K0.0%+129.4%0.093%
11/7/2025Vanguard Group Inc.3,191,557$7.09M0.0%+5.7%4.484%
11/4/2025State of Wyoming82,509$183K0.0%N/A0.116%
8/15/2025Tower Research Capital LLC TRC 40,592$58K0.0%+458.0%0.057%
8/15/2025 Wasatch Advisors LP7,424,662$10.62M0.1%+10.4%10.432%
8/15/2025Man Group plc78,487$112K0.0%-8.3%0.110%
8/15/2025BNP Paribas Financial Markets206,177$295K0.0%+1,039.4%0.290%
8/15/2025Bridgeway Capital Management LLC104,900$150K0.0%-19.2%0.147%
8/15/2025Bank of America Corp DE2,008,004$2.87M0.0%+0.9%2.821%
8/15/2025Adage Capital Partners GP L.L.C.200,000$286K0.0%-87.1%0.281%
8/14/2025Jane Street Group LLC492,612$704K0.0%+3,816.8%0.692%
8/13/2025Invesco Ltd.155,017$222K0.0%+11.1%0.218%
8/12/2025XTX Topco Ltd108,278$155K0.0%+170.0%0.152%
8/12/2025Dynamic Technology Lab Private Ltd21,476$31K0.0%N/A0.030%
8/12/2025Catalyst Funds Management Pty Ltd28,300$40K0.0%N/A0.040%
8/8/2025Geode Capital Management LLC745,053$1.07M0.0%-47.9%1.049%
8/6/2025Savant Capital LLC26,347$38K0.0%N/A0.037%
8/5/2025Crestwood Advisors Group LLC29,000$41K0.0%N/A0.041%
8/1/2025 Y Intercept Hong Kong Ltd52,521$75K0.0%N/A0.074%
7/31/2025R Squared Ltd30,587$44K0.0%N/A0.043%
7/30/2025 Brookstone Capital Management29,325$42K0.0%N/A0.041%
6/27/2025Goldman Sachs Group Inc.622,720$996K0.0%+8.6%0.877%
5/29/2025Rhumbline Advisers89,633$143K0.0%-10.4%0.126%
5/21/2025Acadian Asset Management LLC27,675$43K0.0%N/A0.039%
5/16/2025Goldman Sachs Group Inc.622,720$996K0.0%+8.6%0.877%
Buy this stock today (Ad)

Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race.tc pixel

Get the name, ticker, and full Hotlist before markets open
5/16/2025Jacobs Levy Equity Management Inc.697,653$1.12M0.0%N/A0.983%
5/16/2025AQR Capital Management LLC140,532$225K0.0%+957.6%0.198%
5/14/2025MetLife Investment Management LLC15,893$25K0.0%-44.9%0.022%
5/13/2025American Century Companies Inc.141,986$227K0.0%+6.9%0.200%
5/12/2025Nuveen LLC192,424$308K0.0%N/A0.271%
5/12/2025Invesco Ltd.139,486$223K0.0%+101.6%0.196%
5/9/2025Deutsche Bank AG46,225$74K0.0%N/A0.065%
5/9/2025Charles Schwab Investment Management Inc.474,843$760K0.0%-2.4%0.669%
5/8/2025XTX Topco Ltd40,100$64K0.0%N/A0.056%
4/15/2025SG Americas Securities LLC425,096$680K0.0%N/A0.599%


CCCC Institutional Ownership - Frequently Asked Questions

During the previous two years, 117 institutional investors and hedge funds held shares of C4 Therapeutics. The most heavily invested institutionals were Soleus Capital Management L.P. ($25.12M), Lynx1 Capital Management LP ($24.67M), Wasatch Advisors LP ($16.45M), RA Capital Management L.P. ($15.28M), Bain Capital Life Sciences Investors LLC ($13.70M), Vanguard Group Inc. ($7.09M), and Point72 Asset Management L.P. ($6.85M).Learn more on C4 Therapeutics' institutional investors.

78.81% of C4 Therapeutics' stock is owned by institutional investors. Learn more on CCCC's institutional investor holdings.

Of the 102 institutional investors that purchased C4 Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($8M), Bain Capital Life Sciences Investors LLC ($6.06M), Lynx1 Capital Management LP ($3.25M), Wasatch Advisors LP ($2.49M), Renaissance Technologies LLC ($1.52M), Jane Street Group LLC ($1.20M), and Adage Capital Partners GP L.L.C. ($1.03M).

Institutional investors have bought a total of 24,242,833 shares in the last 24 months. This purchase volume represents approximately $48.62M in transactions.

Of the 15 institutional investors that sold C4 Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Orbimed Advisors LLC ($5.97M), Wasatch Advisors LP ($4.46M), Adage Capital Partners GP L.L.C. ($1.35M), Millennium Management LLC ($835.26K), Geode Capital Management LLC ($685.24K), Dimensional Fund Advisors LP ($135.41K), and BNP Paribas Financial Markets ($125.37K).

Institutional investors have sold a total of 13,789,338 shares in the last 24 months. This volume of shares sold represents approximately $28.17M in transactions.


Related Companies

This page (NASDAQ:CCCC) was last updated on 7/25/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel
Where to Put $100 Before Trump's New Tech Law Rolls Out
The Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...
Brownstone Research | Sponsoredtc pixel